Picture of Agile Therapeutics logo

AGRX — Agile Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Agile Therapeutics Inc expected to post a loss of $7.00 a share - Earnings Preview

* Agile Therapeutics Inc  AGRX.OQ   AGRX.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 9. 
    * The Princeton New Jersey-based  company is expected to
report  a
91.7% increase in revenue to $4.076 million from $2.13 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Agile Therapeutics
Inc is
for a loss of $7.00 per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated August 7 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Agile Therapeutics

See all news